Theseus Pharmaceuticals Inc

NASDAQ THRX

Data sourced from iex and EODHD
Download Data

Theseus Pharmaceuticals Inc Income Statement 2020 - 2023

This table shows the Income Statement for Theseus Pharmaceuticals Inc going from 2020 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Cost of Revenue
M 0 0 0 0 - - - - - - - - - -
Gross Profit
M 0 0 0 0 - - - - - - - - - -
Operating Expenses
M 16 17 17 15 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 5 5 5 5 5 5 4 4 2 2 1 0 0 -
Research and Development (R&D) Expenses
M 12 13 12 10 11 7 7 5 5 4 4 2 1 -
Other Operating Expenses
M 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M 16 17 17 15 - - - - - - - - - -
Operating Income
M -16 -18 -17 -15 -16 -12 -11 -9 -7 -7 -4 -3 -1 -
Interest Expense
M - - 2 2 1 0 0 0 - - - - - -
Non-operating Income/Expense
M 3 3 2 2 1 0 0 0 0 0 0 0 - -
EBT
M -14 -15 -15 -14 -15 -12 -10 -9 -7 -7 -4 -3 -1 -
Income Tax Provision
M 0 - -2 2 -1 0 0 0 0 0 0 0 - -
Income after Tax
M -13 - -12 -15 -14 -11 -10 -9 -7 -7 -4 -3 - -
Non-Controlling Interest
M - 0 0 0 0 0 0 0 0 -1 0 - 0 -
Net Income
M - -15 -15 -14 -15 -12 -10 -9 -7 -6 -4 - -1 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 43,802,221.00 43,736,275.00 42,371,206.00 38,703,777.00 38,585,980.00 38,415,379.00 38,247,970.00 35,877,802.00 35,863,960.00 35,863,960.00 25,367,457.00 25,367,457.00 25,367,457.00 -
EBITDA
M -16 -18 -17 -15 -16 -12 -11 -9 -7 -7 -4 -3 -1 -
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 - 0 - 0 -
EBIT
M -16 -18 -17 -15 -16 -12 -11 -9 -7 -6 -4 - -1 -1
Income from Discontinued Operations
M - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.16 - 16.93 -12.51 8.16 3.70 0.78 0.03 0.03 0.10 0.36 -0.07 - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 0 0 0 0 - 0 -
Gross Profit Margin
% - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email